StonvexLoading…
StonvexStonvexStonvexCore line items from UTHR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.18B | $2.88B | $2.33B | $1.94B |
Operating Income | $1.49B | $1.38B | $1.18B | $979.70M |
Net Income | $1.33B | $1.20B | $984.80M | $727.30M |
EPS (Diluted) | $27.86 | $24.64 | $19.81 | $15.00 |
Total Assets | $7.88B | $7.36B | $7.17B | $6.04B |
Total Liabilities | $783.80M | $920.00M | $1.18B | $1.25B |
Cash & Equivalents | $1.56B | $1.70B | $1.21B | $961.20M |
Free Cash Flow OCF − CapEx | $1.04B | $1.08B | $747.60M | $663.70M |
Shares Outstanding | 43.64M | 44.83M | 47.04M | 46.03M |